AbCellera Biologics Inc (ABCL) EPS is poised to hit -0.13 next quarter: How Investors Can Make It Count the Most?
As on Wednesday, AbCellera Biologics Inc (NASDAQ: ABCL) started slowly as it slid -1.48% to $2.67, before settling in for the price of $2.71 at